Benjamin F. Chu, M.D., Hematologist/Medical Oncologist
Undergraduate: The University of Texas at Austin - 1999 BS
Graduate: University of Pennsylvania - 2001 M.A. Biotechnology, Bioinformatics, & Computational Biology
Medical School: Texas Tech University Health Sciences Center School of Medicine - 2007 MD
Residency: Boston Medical Center 2007 - 2010 Internal Medicine
Fellowship: The Ohio State University Wexner Medical Center 2011-2014 Hematology/Oncology
Member of the International Association for the Study of Lung Cancer
Assistant Clinical Professor at the University of Connecticut School of Medicine
Award for Excellence in Research at Ohio State Medical Center Physician Scientist Research Day, 2014
Texas Medical Association Physician Oncology Education Program- Cancer Education Scholarship, 2006
Howard Hughes Medical Institute- National Institutes of Health Research Scholarship, 2004-2005
Member of the American Society of Clinical Oncology (ASCO)
Member of the American Society of Hematology (ASH)
AREAS OF INTEREST
Head and Neck Cancer
- Chu, B.F., Sell, M., Tucker, J., Shana'ah, A., Hofmeister, C.C., Pichiorri, F., Benson, D.M., & Efebera, Y. (2014). "Lenalidomide and dexamethasone therapy without autologous stem cell transplant (ASCT) in a patient with POEMS syndrome." European Journal of Case Reports in Internal Medicine.
- Chu, B.F. & Otterson, G.A. "Epigenetics in lung cancer - preclinical and clinical advances." (2013). Non-Small Cell Lung Cancer: New Research. Invited Book Chapter. Nova Science Publishers, Inc., pp. 107-128.
- Chu, B.F., Karpenko, M.J., Liu, Z., Aimiuwu, J., Wang, L., Wu, X., Villalona-Calero, M.A., Young, D., Chan, K., Grever, M.R., & Otterson, G.A. (2013). "Phase I study of 5-aza-2'-deoxycytidine in combination with valproic acid in non-small cell lung cancer." Cancer Chemother Pharamcol., 71(1), 115-121.